Home HematologyQuestion

Do you alter your management of Stage I-II DLBCL if it's double or triple hit?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you structure your monitoring for a low-risk leukemic TP53-negative mantle cell lymphoma with 5% MCL cells detected in both peripheral blood and bone marrow, mild splenomegaly, and no lymphadenopathy or B symptoms?

How would you approach treatment with BV-CHP regimen in a patient with newly diagnosed CD30+ ALK- anaplastic large cell lymphoma at high risk for cardiotoxicity?

Do you utilize ctDNA-based MRD testing after frontline chemotherapy for DLBCL?

What is your preferred treatment regimen for a patient with R/R cutaneous T cell lymphoma?

Would you use routine PET scans after two cycles of R-CHOP to guide first-line treatment de-escalation in low-risk (aaIPI = 0) DLBCL patients?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.